Tobacco heated products : a new challenge in tobacco control
Copyright © 2021 SESPAS. Publicado por Elsevier España, S.L.U. All rights reserved..
As cigarette sales decline, the tobacco industry has turned to the sale of heated tobacco products (HTP), which are on the rise. We are concerned with reports erroneously indicating that heated tobacco is associated with a lower risk of cancer and other diseases than conventional cigarettes, citing as a source the Food and Drug Administration (FDA) of the United States. The FDA has indeed authorized the sale of an HTP, but denies that this approval is an endorsement of the product or that it is safe. Philip Morris asked the FDA to approve this product as a "modified risk" tobacco product. However, the Agency denied that the risk to users' health was less than conventional cigarettes, despite emitting less amount of some toxicants. Spain and the European Union should end the regulatory privileges that HTPs have until now. We identified at least five aspects to improve: 1) compliance with the prohibition of HTPs use where smoking is prohibited; 2) control of the prohibition of advertising, promotion, and sponsorship of HTPs; 3) that HTPs carry the same type of labeling as cigarettes; 4) limit that HTPs have characteristic aromas; and 5) treat HTPs fiscally at the same level as cigarettes.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:36 |
|---|---|
| Enthalten in: |
Gaceta sanitaria - 36(2022), 1 vom: 07. Jan., Seite 57-59 |
| Sprache: |
Spanisch |
|---|
| Weiterer Titel: |
Los productos de tabaco calentado: nuevo reto en el control del tabaco |
|---|
| Beteiligte Personen: |
Peruga, Armando [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Daños de salud |
|---|
| Anmerkungen: |
Date Completed 21.01.2022 Date Revised 13.12.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.gaceta.2020.12.033 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM321237110 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM321237110 | ||
| 003 | DE-627 | ||
| 005 | 20231227130435.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||spa c | ||
| 024 | 7 | |a 10.1016/j.gaceta.2020.12.033 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1224.xml |
| 035 | |a (DE-627)NLM321237110 | ||
| 035 | |a (NLM)33563478 | ||
| 035 | |a (PII)S0213-9111(21)00007-8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a spa | ||
| 100 | 1 | |a Peruga, Armando |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Tobacco heated products |b a new challenge in tobacco control |
| 246 | 3 | 3 | |a Los productos de tabaco calentado: nuevo reto en el control del tabaco |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 21.01.2022 | ||
| 500 | |a Date Revised 13.12.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2021 SESPAS. Publicado por Elsevier España, S.L.U. All rights reserved. | ||
| 520 | |a As cigarette sales decline, the tobacco industry has turned to the sale of heated tobacco products (HTP), which are on the rise. We are concerned with reports erroneously indicating that heated tobacco is associated with a lower risk of cancer and other diseases than conventional cigarettes, citing as a source the Food and Drug Administration (FDA) of the United States. The FDA has indeed authorized the sale of an HTP, but denies that this approval is an endorsement of the product or that it is safe. Philip Morris asked the FDA to approve this product as a "modified risk" tobacco product. However, the Agency denied that the risk to users' health was less than conventional cigarettes, despite emitting less amount of some toxicants. Spain and the European Union should end the regulatory privileges that HTPs have until now. We identified at least five aspects to improve: 1) compliance with the prohibition of HTPs use where smoking is prohibited; 2) control of the prohibition of advertising, promotion, and sponsorship of HTPs; 3) that HTPs carry the same type of labeling as cigarettes; 4) limit that HTPs have characteristic aromas; and 5) treat HTPs fiscally at the same level as cigarettes | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Daños de salud | |
| 650 | 4 | |a Exposición reducida | |
| 650 | 4 | |a Health damage | |
| 650 | 4 | |a IQOS | |
| 650 | 4 | |a Industria tabaquera | |
| 650 | 4 | |a Modified risk | |
| 650 | 4 | |a Reduced exposure | |
| 650 | 4 | |a Riesgo modificado | |
| 650 | 4 | |a Tabaco | |
| 650 | 4 | |a Tobacco | |
| 650 | 4 | |a Tobacco industry | |
| 700 | 1 | |a Rodríguez Lozano, Francisco |e verfasserin |4 aut | |
| 700 | 1 | |a López, María José |e verfasserin |4 aut | |
| 700 | 1 | |a Córdoba García, Rodrigo |e verfasserin |4 aut | |
| 700 | 1 | |a Nerín, Isabel |e verfasserin |4 aut | |
| 700 | 1 | |a Sureda, Xisca |e verfasserin |4 aut | |
| 700 | 1 | |a Fernández, Esteve |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Gaceta sanitaria |d 1991 |g 36(2022), 1 vom: 07. Jan., Seite 57-59 |w (DE-627)NLM012723282 |x 1578-1283 |7 nnns |
| 773 | 1 | 8 | |g volume:36 |g year:2022 |g number:1 |g day:07 |g month:01 |g pages:57-59 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.gaceta.2020.12.033 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 36 |j 2022 |e 1 |b 07 |c 01 |h 57-59 | ||